Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Aug 15, 2023; 15(8): 1366-1383
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1366
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1366
Figure 1 Relative expression level of LINC01268 in gastric cancer.
A: The relative expression level of LINC01268 in 62 cases of gastric cancer (GC) tissues was higher than that of adjacent noncancerous tissues (ANTs). Expression levels were normalized to ACTB levels; B: The expression level of LINC01268 was up-regulated in 39 GC tissues and down-regulated in 23 GC tissues [bars represent the ratio between the expression levels in GC tissues and ANTs (C/N, log scale) from the 62 patients]; C: The relative expression levels of LINC01268 in GC cell lines MGC80-3 and AGS were higher than those in normal gastric mucosa epithelial cell line GES-1. Expression levels were normalized to GAPDH levels. The results were shown as the mean ± SD. bP < 0.01, dP < 0.0001. GC: Gastric cancer; ANT: Adjacent noncancerous tissue.
- Citation: Tang LH, Ye PC, Yao L, Luo YJ, Tan W, Xiang WP, Liu ZL, Tan L, Xiao JW. LINC01268 promotes epithelial-mesenchymal transition, invasion and metastasis of gastric cancer via the PI3K/Akt signaling pathway and targeting MARCKS. World J Gastrointest Oncol 2023; 15(8): 1366-1383
- URL: https://www.wjgnet.com/1948-5204/full/v15/i8/1366.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i8.1366